Biotechnology represents one of the most lucrative sectors in the Asia-Pacific region. Asian governments are making biotechnology a top priority, recognizing the industry's tremendous growth potential and strategic importance. With the biotech industry approaching maturing phase in developed markets of the US, Europe and Japan, most biotech companies are eyeing emerging markets such as India for further growth. As per our new research report "Asia Pacific Biotechnology Market (2008-2012)", the biotech market in India is forecasted to grow at a CAGR of more than 25% between 2010-11and 2012-13 on the back of strong government support, high investments in R&D and low cost factor.
We have done an extensive research and analysis of biotech markets in the Asia Pacific countries and found that many of them are growing at a double digit growth rate. Low cost is the most prominent factor that has boosted investments in these markets. Our report has also studied other market drivers to get insight into investment scenario and prospective developments.
"The Asia-Pacific biotech market is undergoing through transition phase which has given rise to several new market trends. Major biotech companies are curiously watching these changes and devising strategies to tap the existing opportunities for their own benefits," said a Research Analyst at RNCOS.
Besides, the report provides complete information about the biotech markets in other Asia-Pacific countries such as China, Japan, Malaysia, Thailand and Singapore, along with their future growth prospects. Our research report also highlights certain roadblocks that are restraining growth in the industry and will prove very beneficial to clients in devising their future strategy.
"Asia Pacific Biotechnology Market (2008-2012)" gives an extensive and objective analysis of the biotechnology market in the Asia Pacific region. It features valuable information about future directions, supplemented with facts and figures. Thus, the report serves as a useful guide for pharma and biotech companies, investors and consultants who are planning to enter the Asia Pacific biotech market.
For more information visit: http://www.rncos.com/Report/IM138.htm |
